HeadlineShine

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

CNBC ·First reported
CNBC
Image: CNBC

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

Summary from CNBC

Read the full story on CNBC
React

Trending now

ESPN
Sports8 sources·

What channel is Brewers vs Rays in World Series Game 1 on? Time, TV
CBS News
Business8 sources·

2 ex-FBI officials charged with lying about Hunter Biden laptop probe
The Hollywood Reporter
Entertainment2 sources·

Quentin Tarantino Surprises Fans With 17 Minutes of ‘The Further Mis-Adventures of Cliff Booth’ at AFI Fest
Yahoo Sports
Sports3 sources·

Cooper Flagg injury update: Mavericks star exits after hard Pacers foul leads to skirmish

More business

See all →
CNBC
Business5 sources·

Justice Department sues to block Alaska Senate race results if Republican loses
New York Times
BusinessNew York Times·

Noah Adams, Longtime Host of ‘All Things Considered,’ Has Died at 84
New York Times
Business4 sources·

Trump administration cancels some Canada tariffs, Sen. Susan Collins says
CNBC
BusinessCNBC·

I quit my marketing job to walk dogs for 4 months: It's 'one of the most valuable professional experiences I've ever had'
CBS News
BusinessCBS News·

Arian Simone on her "Fearless Fund" and the battle to support Black women entrepreneurs
CNBC
BusinessCNBC·

An ex-bookkeeper spent $375 to launch a sewing business: 'I hadn't felt so sure about something like that in a long time'

Top stories in the United States

See all →
ESPN
Sports3 sources·

Indiana Fever fire general manager Amber Cox amid front office shakeup
CBS News
Tech7 sources·

The iPhone Duo should have been an iPad
CBS Sports
Sports5 sources·

UFC 333: Volkanovski vs. Evloev live results
ESPN
Sports3 sources·

Jose Mourinho laments Real Madrid's El Clasico disadvantage against Barcelona
Yahoo Sports
Sports6 sources·

Knicks tricked employees with championship ring phishing test
CBS Sports
Sports4 sources·

Jesse Legree to return to Oregon State for 2027 season